Latest Articles

Publication Date
All News Scientific
Puxitatug Samrotecan Demonstrates Efficacy, Manageable Safety in Advanced/Metastatic Endometrial Cancer - OncLive

Puxitatug Samrotecan Demonstrates Efficacy, Manageable Safety in Advanced/Metastatic Endometrial Cancer OncLive

Published: March 16, 2025, 7:29 p.m.
Read Full Article
Infigratinib shows promising efficacy and tolerability in pediatric achondroplasia - 2 Minute Medicine

Infigratinib shows promising efficacy and tolerability in pediatric achondroplasia 2 Minute Medicine

Published: March 11, 2025, 8:13 p.m.
Read Full Article
The study on the clinical efficacy of endometrial receptivity analysis and influence factors of displaced window of implantation - Nature.com

The study on the clinical efficacy of endometrial receptivity analysis and influence factors of displaced window of implantation Nature.com

Published: March 1, 2025, 2:30 p.m.
Read Full Article
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - BioMed Central

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis BioMed Central

Published: Feb. 28, 2025, 10:47 a.m.
Read Full Article
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - bmcwomenshealth.biomedcentral.com

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis bmcwomenshealth.biomedcentral.com

Published: Feb. 28, 2025, 10:47 a.m.
Read Full Article
(PDF) The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors - ResearchGate

(PDF) The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors ResearchGate

Published: Feb. 14, 2025, 3:13 a.m.
Read Full Article
(PDF) Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - ResearchGate

(PDF) Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment ResearchGate

Published: Jan. 25, 2025, 1:07 p.m.
Read Full Article
Peripheral Blood NLR Predicts LEN/PEM Efficacy in Endometrial Cancer - Physician's Weekly

Peripheral Blood NLR Predicts LEN/PEM Efficacy in Endometrial Cancer Physician's Weekly

Published: Dec. 31, 2024, 12:27 p.m.
Read Full Article
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - Frontiers

Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment Frontiers

Published: Dec. 24, 2024, 7:10 p.m.
Read Full Article
Efficacy, Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer - Medpage Today

Efficacy, Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer Medpage Today

Published: Oct. 23, 2024, 2:47 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!